Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2018 Dec 29

PMID 30590974

Citations 40

Authors

Kurt W Prins

Thenappan Thenappan

E Kenneth Weir

Rajat Kalra

Marc Pritzker

Stephen L Archer

Affiliations

Soon will be listed here.

Citing Articles

Ferroptosis-Mediated Inflammation Promotes Pulmonary Hypertension.

Kazmirczak F, Vogel N, Prisco S, Patterson M, Annis J, Moon R Circ Res. 2024; 135(11):1067-1083.

PMID: 39421926 PMC: 11560515. DOI: 10.1161/CIRCRESAHA.123.324138.

Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats.

Corboz M, Nguyen T, Stautberg A, Cipolla D, Perkins W, Chapman R J Aerosol Med Pulm Drug Deliv. 2024; 37(5):241-283.

PMID: 39388691 PMC: 11502635. DOI: 10.1089/jamp.2024.0016.

Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension.

Reddy T, Barrios R, Bernicker E, Qian W, Chang J, Safdar Z Pulm Circ. 2024; 14(3):e12426.

PMID: 39224834 PMC: 11366960. DOI: 10.1002/pul2.12426.

Pulmonary hypertension and the potential of 'drug' repurposing: A case for African medicinal plants.

Jacobs S, Payne C, Shaboodien S, Kgatla T, Pretorius A, Jumaar C Afr J Thorac Crit Care Med. 2024; 30(2):e1352.

PMID: 39171151 PMC: 11334905. DOI: 10.7196/AJTCCM.2024.v30i2.1352.

Integrated bioinformatics analysis and experimental animal models identify a robust biomarker and its correlation with the immune microenvironment in pulmonary arterial hypertension.

Juaiti M, Feng Y, Tang Y, Liang B, Zha L, Yu Z Heliyon. 2024; 10(8):e29587.

PMID: 38660271 PMC: 11040037. DOI: 10.1016/j.heliyon.2024.e29587.

References

Deftereos S, Giannopoulos G, Panagopoulou V, Bouras G, Raisakis K, Kossyvakis C . Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study. JACC Heart Fail. 2014; 2(2):131-7. DOI: 10.1016/j.jchf.2013.11.006. View

Vonk Noordegraaf A, Westerhof B, Westerhof N . The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension. J Am Coll Cardiol. 2017; 69(2):236-243. DOI: 10.1016/j.jacc.2016.10.047. View

Zhou X, Chen J . Is treatment with trimetazidine beneficial in patients with chronic heart failure?. PLoS One. 2014; 9(5):e94660. PMC: 4010408. DOI: 10.1371/journal.pone.0094660. View

Lis K, Kuzawinska O, Balkowiec-Iskra E . Tumor necrosis factor inhibitors - state of knowledge. Arch Med Sci. 2015; 10(6):1175-85. PMC: 4296073. DOI: 10.5114/aoms.2014.47827. View

Archer S, Fang Y, Ryan J, Piao L . Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension. Pulm Circ. 2013; 3(1):144-52. PMC: 3641722. DOI: 10.4103/2045-8932.109960. View

Humbert M, Sitbon O, Yaici A, Montani D, OCallaghan D, Jais X . Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 2010; 36(3):549-55. DOI: 10.1183/09031936.00057010. View

Aghamohammadzadeh R, Zhang Y, Stephens T, Arons E, Zaman P, Polach K . Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension. FASEB J. 2016; 30(7):2511-27. PMC: 4904292. DOI: 10.1096/fj.201500042. View

Al-Bari M . Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2015; 70(6):1608-21. PMC: 7537707. DOI: 10.1093/jac/dkv018. View

Traish A, Kang H, Saad F, Guay A . Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. J Sex Med. 2011; 8(11):2960-82. DOI: 10.1111/j.1743-6109.2011.02523.x. View

10.

Chaitman B . Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation. 2006; 113(20):2462-72. DOI: 10.1161/CIRCULATIONAHA.105.597500. View

11.

Thenappan T, Roy S, Duval S, Glassner-Kolmin C, Gomberg-Maitland M . β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis. Circ Heart Fail. 2014; 7(6):903-10. DOI: 10.1161/CIRCHEARTFAILURE.114.001429. View

12.

Mochizuki M, Yano M, Oda T, Tateishi H, Kobayashi S, Yamamoto T . Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure. J Am Coll Cardiol. 2007; 49(16):1722-32. DOI: 10.1016/j.jacc.2007.01.064. View

13.

Spiekerkoetter E, Sung Y, Sudheendra D, Bill M, Aldred M, van de Veerdonk M . Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2015; 192(2):254-7. PMC: 4532822. DOI: 10.1164/rccm.201411-2061LE. View

14.

Heresi G, Aytekin M, Hammel J, Wang S, Chatterjee S, Dweik R . Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension. Eur Respir J. 2013; 43(3):912-4. DOI: 10.1183/09031936.00164713. View

15.

Ryan J, Huston J, Kutty S, Hatton N, Bowman L, Tian L . Right ventricular adaptation and failure in pulmonary arterial hypertension. Can J Cardiol. 2015; 31(4):391-406. PMC: 4385216. DOI: 10.1016/j.cjca.2015.01.023. View

16.

Zhang H, Wang D, Li M, Plecita-Hlavata L, DAlessandro A, Tauber J . Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis. Circulation. 2017; 136(25):2468-2485. PMC: 5973494. DOI: 10.1161/CIRCULATIONAHA.117.028069. View

17.

Cheng F, Desai R, Handy D, Wang R, Schneeweiss S, Barabasi A . Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat Commun. 2018; 9(1):2691. PMC: 6043492. DOI: 10.1038/s41467-018-05116-5. View

18.

Dai Z, Zhu M, Peng Y, Jin H, Machireddy N, Qian Z . Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension. Am J Respir Crit Care Med. 2018; 198(6):788-802. PMC: 6222462. DOI: 10.1164/rccm.201709-1835OC. View

19.

Morales A, Haubrich R, Hwang J, Asakura H, Yen S . The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf). 1999; 49(4):421-32. DOI: 10.1046/j.1365-2265.1998.00507.x. View

20.

Moore K, Aithal G . Guidelines on the management of ascites in cirrhosis. Gut. 2006; 55 Suppl 6:vi1-12. PMC: 1860002. DOI: 10.1136/gut.2006.099580. View